Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 11168
Gene Symbol: PSIP1
PSIP1
0.010 AlteredExpression phenotype BEFREE Within the FM group, patients with arthralgia had higher anti-DFS70 antibody values compared to those without arthralgia (p = 0.024); antibody levels were also higher in patients with sleep disturbances relative to those without sleep issues (p = 0.024). 29166758 2019
Entrez Id: 2099
Gene Symbol: ESR1
ESR1
0.010 Biomarker phenotype BEFREE We used general linear models to examine associations of sleep disturbance with markers of tumor aggressiveness among cases: estrogen receptor (ER) status, progesterone receptor (PR) status, and human epidermal growth factor receptor-2 (HER2) status; tumor size, stage, grade, lymph node involvement, and presence of metastasis. 29198300 2018
Entrez Id: 6310
Gene Symbol: ATXN1
ATXN1
0.020 Biomarker phenotype BEFREE We report two cases of sleep disturbance, fatigue and excessive daytime somnolence in individuals with SCA1 and their progress through several therapies. 20045119 2010
Entrez Id: 590
Gene Symbol: BCHE
BCHE
0.010 Biomarker phenotype BEFREE We investigated whether donepezil, a cholinesterase inhibitor, can be used to treat sleep disturbances in patients with dementia with Lewy bodies (DLB). 28236784 2017
Entrez Id: 4128
Gene Symbol: MAOA
MAOA
0.020 Biomarker phenotype BEFREE We hypothesized that the risk of sleep disturbance is, at least in part, influenced by the availability of serotonin used for melatonin synthesis secondary to polymorphic variation at the enzyme monoamine oxidase A (MAO-A). 16944667 2006
Entrez Id: 3060
Gene Symbol: HCRT
HCRT
0.090 AlteredExpression phenotype BEFREE We found that the age at which orexin activity starts to deviate from normal activity pattern coincides with that of sleep disturbances as well as the beta activity. 30915710 2019
Entrez Id: 80816
Gene Symbol: ASXL3
ASXL3
0.110 GeneticVariation phenotype BEFREE We describe a patient with severe developmental delay, feeding problems, short stature, autism, and sleep disturbance with a heterozygous de novo splicing mutation in the ASXL3 gene. 27075689 2016
Entrez Id: 907
Gene Symbol: CCT
CCT
0.010 Biomarker phenotype BEFREE We assessed sleep disturbance repeatedly in: a) 523 adults with recurrent MDD who consented to 12-14 weeks of acute-phase cognitive therapy (A-CT) and b) 241 A-CT responders at elevated risk for depression relapse/recurrence who were randomized to 8 months of continuation-phase treatment (CCT vs. fluoxetine vs. matched pill placebo) and followed protocol-treatment-free for 24 months. 31735410 2020
Entrez Id: 7369
Gene Symbol: UMOD
UMOD
0.010 Biomarker phenotype BEFREE To investigate the effects and mechanisms of l-THP on sleep disturbance in a neuropathic pain-like condition. 31172225 2019
Entrez Id: 2736
Gene Symbol: GLI2
GLI2
0.010 Biomarker phenotype BEFREE To investigate the effects and mechanisms of l-THP on sleep disturbance in a neuropathic pain-like condition. 31172225 2019
Entrez Id: 348
Gene Symbol: APOE
APOE
0.060 GeneticVariation phenotype BEFREE To determine whether sleep medication mediates the risk of developing MCI for individuals with sleep disturbance and/or APOE <sub>e4</sub>, we analyzed the National Alzheimer's Coordinating Center Uniform Data Set. 30359892 2018
Entrez Id: 23314
Gene Symbol: SATB2
SATB2
0.110 GeneticVariation phenotype BEFREE To determine the nature and frequency of behavioral phenotypes and sleep disturbances in individuals with SATB2-associated syndrome (SAS). 31420882 2019
Entrez Id: 4791
Gene Symbol: NFKB2
NFKB2
0.010 Biomarker phenotype BEFREE To attempt to replicate the associations found in our previous study of patients and family caregivers between interleukin 6 (IL6) and nuclear factor kappa beta 2 (NFKB2) and sleep disturbance and to identify additional genetic associations in a larger sample of patients with breast cancer. 24012192 2014
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.050 Biomarker phenotype BEFREE To attempt to replicate the associations found in our previous study of patients and family caregivers between interleukin 6 (IL6) and nuclear factor kappa beta 2 (NFKB2) and sleep disturbance and to identify additional genetic associations in a larger sample of patients with breast cancer. 24012192 2014
Entrez Id: 4810
Gene Symbol: NHS
NHS
0.010 Biomarker phenotype BEFREE To assess the clinical effectiveness and safety of NHS-relevant pharmacological and non-pharmacological interventions to manage sleep disturbance in children and young people with NDs, who have non-respiratory sleep disturbance. 30382936 2018
Entrez Id: 55558
Gene Symbol: PLXNA3
PLXNA3
0.010 GeneticVariation phenotype BEFREE THREAT was associated with sleep disturbance (odds ratio [OR] = 2.798, p < .0001), as was HURT (OR = 2.683, p < .0001), SEX (OR = 3.237, p < .0001), SEXyr (OR = 7.741, p < .0001), and HURTyr (OR = 7.497, p < .0001). 26149676 2017
Entrez Id: 3060
Gene Symbol: HCRT
HCRT
0.090 AlteredExpression phenotype BEFREE Those with both MCI and sleep disturbance appear to have more pronounced functional connectivity alterations in temporoparietal brain regions and higher levels of the wake-promoting neurotransmitter orexin in cerebrospinal fluid than those with MCI alone. 29256922 2018
Entrez Id: 10261
Gene Symbol: IGSF6
IGSF6
0.010 Biomarker phenotype BEFREE This study showed that DORA-12 can affect the sleep disturbance that is associated with a history of adolescent ethanol exposure and also has several other sleep-promoting effects that are equivalent in both ethanol and control rats. 31659377 2019
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.050 Biomarker phenotype BEFREE This study examined Interleukin-6 (IL-6) relations with BMI, tobacco use history, and sleep disturbances in patients undergoing surgery for suspected gynecologic cancer. 31368718 2019
Entrez Id: 3060
Gene Symbol: HCRT
HCRT
0.090 Biomarker phenotype BEFREE This review describes how neurotoxic and genetic manipulations of rats and mice have been utilized to reproduce some of the major sleep disturbances associated with PD and to what extent these abnormalities can be linked to nondopaminergic dysfunction, affecting for instance noradrenaline, serotonin, and orexin transmission. 31827439 2019
Entrez Id: 348
Gene Symbol: APOE
APOE
0.060 GeneticVariation phenotype BEFREE This investigation found a significant relationship between presence of APOE ε4 allele and objective sleep disturbances measured by both actigraphy and PSG, but not subjective sleep complaints in a healthy population screened for dementia. 27777343 2016
Entrez Id: 5080
Gene Symbol: PAX6
PAX6
0.010 GeneticVariation phenotype BEFREE This cross-sectional descriptive study examined pineal volume, melatonin secretion and sleep disturbance in 37 patients with PAX6+/− (age 15.3 ± 9.9 years) and 17 healthy controls (16.0 ± 7.2 years), within an inpatient setting at the Clinical Research Center of the National Institutes of Health, Bethesda, Maryland, USA. 26439359 2016
Entrez Id: 594857
Gene Symbol: NPS
NPS
0.010 Biomarker phenotype BEFREE These results suggest that NPSR upregulation in the amygdala is presumably related to the PSD-induced anxiety-like behavior and sleep disturbances, and that NPS counteracts PSD-induced anxiety-like behavior and sleep disturbances possibly through activating the neurons bearing NPSR in the amygdala. 29559896 2018
Entrez Id: 2030
Gene Symbol: SLC29A1
SLC29A1
0.010 AlteredExpression phenotype BEFREE These results suggest that binge alcohol consumption-induced down-regulation of ENT1 expression may disrupt sleep homeostasis and cause sleep disturbances. 29804297 2018
Entrez Id: 3060
Gene Symbol: HCRT
HCRT
0.090 Biomarker phenotype BEFREE These results identify a novel mechanistic link between mTOR and orexin in the hypothalamus related to sleep dysfunction and suggest a targeted therapeutic approach to sleep disorders in TSC. 31605778 2020